Literature DB >> 15422097

A quantitative antibody response of man to infection or vaccination with Pasteurella tularensis.

M M ALEXANDER.   

Abstract

A polysaccharide antigen, prepared from a virulent strain of Past. tularensis by phenol extraction, was employed in assaying the antibody in sera from persons recovered from infection with, or vaccinated with Past. tularensis, using the serological technique of quantitative precipitation. Antibody levels in sera of individuals vaccinated with or recovered from infection with Past. tularensis were found to resemble those observed in similar studies by other investigators, such as the antibody response to pneumococcal antigen, meningococcal polysaccharide, and blood group substances. It is suggested that the value of actively or of passively acquired antibody to an individual exposed to tularemia is dependent not on the amount of antibody alone, but also on the amount of antigen with which the antibody is capable of combining.

Entities:  

Keywords:  TULAREMIA

Mesh:

Substances:

Year:  1950        PMID: 15422097      PMCID: PMC2136022          DOI: 10.1084/jem.92.1.51

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  ANTITULARENSE SERUM: CORRELATION BETWEEN PROTECTIVE CAPACITY FOR WHITE RATS AND PRECIPITABLE ANTIBODY CONTENT.

Authors:  L Foshay; I Ruchman; P S Nicholes
Journal:  J Clin Invest       Date:  1947-07       Impact factor: 14.808

2.  THE IMMUNE RESPONSE OF HUMAN BEINGS TO BRIEF INFECTIONS WITH PNEUMOCOCCUS.

Authors:  M Heidelberger; D G Anderson
Journal:  J Clin Invest       Date:  1944-09       Impact factor: 14.808

3.  QUANTITATIVE MICRO-ESTIMATION OF ANTIBODIES IN THE SERA OF MAN AND OTHER ANIMALS.

Authors:  M Heidelberger; C F Macpherson
Journal:  Science       Date:  1943-04-30       Impact factor: 47.728

4.  A SIMPLE METHOD FOR PREPARING ANTIGENIC SUBSTANCES FROM THE TYPHOID BACILLUS.

Authors:  J W Palmer
Journal:  Science       Date:  1940-08-16       Impact factor: 47.728

5.  Vaccine Prophylaxis against Tularemia in Man.

Authors:  L Foshay; W H Hesselbrock; H J Wittenberg; A H Rodenberg
Journal:  Am J Public Health Nations Health       Date:  1942-10

6.  THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND HOMOLOGOUS ANTIBODY : III. A QUANTITATIVE STUDY AND A THEORY OF THE REACTION MECHANISM.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307

7.  IMMUNOCHEMICAL STUDIES ON BLOOD GROUPS : I. ESTIMATION OF A AND B ISOANTIBODIES IN HUMAN SERUM BY THE QUANTITATIVE PRECIPITIN METHOD.

Authors:  E A Kabat; A E Bezer
Journal:  J Exp Med       Date:  1945-09-01       Impact factor: 14.307

8.  ANTIBODY FORMATION IN MEN FOLLOWING INJECTION OF FOUR TYPE-SPECIFIC POLYSACCHARIDES OF PNEUMOCOCCUS.

Authors:  M Heidelberger; C M Macleod; R G Hodges; W G Bernhard; M M di Lapi
Journal:  J Exp Med       Date:  1947-02-28       Impact factor: 14.307

9.  PREPARATION OF THE TYPE-SPECIFIC POLYSACCHARIDE OF THE TYPE I MENINGOCOCCUS AND A STUDY OF ITS EFFECTIVENESS AS AN ANTIGEN IN HUMAN BEINGS.

Authors:  E A Kabat; H Kaiser; H Sikorski
Journal:  J Exp Med       Date:  1944-10-01       Impact factor: 14.307

10.  ANTIBODY FORMATION IN VOLUNTEERS FOLLOWING INJECTION OF PNEUMOCOCCI OR THEIR TYPE-SPECIFIC POLYSACCHARIDES.

Authors:  M Heidelberger; C M Macleod; S J Kaiser; B Robinson
Journal:  J Exp Med       Date:  1946-03-31       Impact factor: 14.307

  10 in total
  4 in total

1.  [Studies on antigen preparations from Bacterium tularense].

Authors:  H KNOTHE; G HAVEMEISTER
Journal:  Z Hyg Infektionskr       Date:  1960

2.  Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components.

Authors:  P Hambleton; C G Evans; A M Hood; R E Strange
Journal:  Br J Exp Pathol       Date:  1974-08

3.  Antigens of Pasteurella tularensis: preparative procedures.

Authors:  J E Nutter
Journal:  Appl Microbiol       Date:  1971-07

4.  Infection-immunity in tularemia: specificity of cellular immunity.

Authors:  J L Claflin; C L Larson
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.